Outsourcing in Clinical Trials East Coast 2023

Discover effective strategies for outsourcing clinical trial operations to ensure trials run smoothly and within budget

23 - 24

May

2023
  • Valley Forge Casino Resort, King of Prussia, PA, USA
  • Complimentary
  • Why attend?
  • Agenda
  • 2023 Speakers
  • Plan Your Visit
  • Sponsors
  • Media Centre
  • Contact Us
close

Why attend?

WHAT TO EXPECT FOR 2023?

450+

Attendees

70+

Exhibitors

30+

Speakers

450+

Attendees

70+

Exhibitors

30+

Speakers

See What It's All About

Agenda

  • 23 May 2023
  • 24 May 2023
Expand All

Streams

Stream one

Outsourcing and Clinical Operations

Stream two

Clinical Innovation & Technology

7:30 AM

Registration & Refreshments

8:20 AM

Chairperson’s opening remarks

Speakers

Peter O’Neill
Senior Director, Clinical Operations, Cellectis

8:30 AM

Keynote We Are All At-Risk of Being Obsolete: Earning Our Place in the Future of Clinical Research

Clinical research is a crucial part of delivering a healthy society, and no stakeholder involved in the process today has a "right" to be here tomorrow. There are futures where every entity in research is at risk of being made obsolete. How can we best avoid complacence and ensure we are all earning the right to be at this table?

Speakers

Craig H Lipset
Advisor and Founder, Clinical Innovation Partners

9 AM

State of the Global Biotech Landscape: Where the opportunities lie

  • State of Global Clinical Trials Landscape
  • Lasting COVID Impact
  • Biotech Economic Landscape
  • APAC as a Focus for Clinical Development

Speakers

Alex Ireland
Associate Director Business Development, Novotech

9:30 AM

Artificial Intelligence & the future of clinical trials: the potential of AI to help with study planning

  • Identify and assess the possibilities for AI in your clinical trial
  • Understanding the technologies behind AI such as machine learning, deep learning, neural networks, and algorithms
  • Social and ethical implications of Artificial Intelligence
  • A contextual understanding of AI, its history, and evolution, helping you to make relevant predictions for its future trajectory.
  • Looking at how to successfully implement AI into your clinical trial

Speakers

Venkat Sethuraman, Ph.D MBA
Head of Global Biometrics and Data Sciences, Bristol Myers Squibb

10 AM

Optimize Your Trial Execution with the Strategic Use of an Experienced Technology Solutions Team

It takes more than reading a protocol to design and implement technology for a successful clinical trial. It takes years of knowledge and experience to fully understand the risks and provide meaningful insights into best practices that ensure all stakeholders achieve their goals. Before and during a clinical trial, planning decisions across many complex processes is required.

Areas of discussion will include how an expert and experienced team can set up your organization for success in all phases, including.

  • study design
  • recommendations
  • blinding concerns
  • mid-study changes
  • supply management

 

Speakers

Kevin Collier
VP, Medidata

10:30 AM

Morning Refreshments & Networking

11 AM

Strengthening patient relationships authentically to enhance the therapeutic development process

Abstract: Gain a comprehensive understanding of a patient’s journey to advocacy highlighting important pillars of successful patient engagement directly from a patient advocate’s experiences. Understanding and recognizing the barriers, burdens, knowledge gaps, and needs of patients allows for strengthened patient relationships and optimizes long term gains in patient engagement strategies

  • Treating the patient as more than a consumer builds the foundation for patient relationships
  • Recognizing and mitigating the barriers patient trial participation and retention
  • Understanding the value of incorporating the patient voice from the inception and design of research and trials through drug development
  • Improving health literacy and ensuring transparency builds trust
  • Maintaining patient relationships through a feedback loop of dissemination of trial results and co-creation in design strengthens future research

Speakers

Ella Balasa
Patient Advocate, speaker, published writer, and health engagement consultant

11:30 AM

The Last Millimeter is Everything: Essential Guide for Home Visits

  • Home visits have evolved since their inception in 2003
  • Services possible in 2023 – an overview of what is possible today
  • Sourcing the right professionals for visits is essential to success

Speakers

Ellen Weiss
Vice President, In-Home Solutions, Decentralized Clinical Trials, PCM Trials

12 PM

Panel: Reversing the Conversation: What the clinical trial industry really wants from its service providers

We’ve all had to sit through several pitches from vendor companies telling us what they can do for us, but now it’s time to reverse the conversation! Hear from the trial industry as they discuss the services, they would like to see from their solution providers, including:

  • What they like to see in an outsourced partner organization
  • What they would like a partner to know about them / how they work
  • What things do they need a partner to do and what they don’t need!
  • What things can be best done in house?

Speakers

Kathleen Cohen
Head of Clinical Operations, Marinus Pharma
Adam Kinsey
Associate Vice President, Global Clinical Trial Operations (GCTO), Head of GCTO North America, Merck Novotech
Rosalie Filling
Vice President, Senior Global Head R&D Operations, Endo Pharmaceuticals
Alex Ireland
Associate Director Business Development, Novotech

12:30 PM

Clinical Trial Liaisons’ Support of Psychedelic Clinical Trials

  • Psychedelic-assisted therapy has shown potential in the treatment of severe mood and anxiety disorders, including major depressive disorder (MDD) and post-traumatic stress disorder (PTSD)
  • Worldwide is a leader in psychedelics and understands the importance of selecting sites that have the appropriate support services as well as specialized training
  • Worldwide Clinical Trial Liaisons (CTL) provide support to sites as they navigate psychedelic clinical trials, helping sites integrate psychedelic clinical studies into their practice and manage expectations

Speakers

Alison Bedenkop
Senior Director, Patient Recruitment and Retention, Worldwide Clinical Trials

1 PM

Lunch and networking

2 PM

Protecting our planet: Sustainable drug development

  • Understanding the environmental and social impacts of clinical trials
  • Collaborating with supplier ecosystems to drive sustainability goals
  • Sustainability by design: innovation and changing behaviours

Speakers

Anthony Fuller
Global Head of Sourcing, Mitsubishi Tanabe Pharma Development America

2:30 PM

A Clinical Outsourcing Model That’s As Agile As Your Development Program

The clinical development landscape is entering a phase of accelerated innovation. Is your clinical outsourcing strategy ready to evolve and adapt to the new trial designs, skills, geographies and technologies to deliver on those needs? This session will explore outsourcing models and trends, as well as emerging models and metrics to consider

Speakers

Neil Berger
Vice President, FSP Commercial and Operational Strategy, Parexel

3 PM

Encouraging public health literacy, patient education and engagement; informing and empowering patients and the public as partners in clinical research

  • Focusing on nurturing our established relationships, building new ones, and on identifying and developing new opportunities.
  • Discussing how to serve patient communities and clinical research stakeholders throughout the world with the highest quality educational and advocacy services

Speakers

Jill McNair
Chief Growth Officer, CISCRP

3:30 PM

Afternoon refreshments, networking and Apple prize draw

4 PM

How CRO’s can help sponsors be the sponsor of choice, a partnership with CRO’s population of sites and conducting clinical trials

  • Removing the bias for sites to engage with CROs in the same way as sponsors
  • The ability to leverage a CRO’s global reach for clinical trial site footprint

Speakers

Adam Barrows
Executive Director - Solid Tumour TA Head, Bristol Myers Squibb

4:30 PM

Innovative Processes to Better Address Today’s Trial Dynamics

  • Supply Chain Efficiency
  • Why do extra work and spend more money than necessary?

 

  • Payment Process Efficiency
  • Leverage an existing workflow process that sites use everyday

 

  • Understanding the Total Value a Vendor Can Provide
  • Select a vendor that can demonstrate its total value (and make you look good in the eyes of your company)

Speakers

Tom Gottschalk
Senior Director, Clinical Business Development TrialCard™, Mercalis

5 PM

Chairperson’s closing remarks followed by Drinks Reception

END OF DAY 1 AND NETWORKING DRINKS

10:30 AM

Morning Refreshments & Networking

11 AM

Data Management in Oncology; the importance of using suitable technology in your clinical trial, leading to a manageable data structure

  • Challenges: How we collect data – number of data forms and adverse effects in oncology
  • Using the right technology
  • Understanding the importance of data
  • Looking at how to manage your data structure

Speakers

Narayan Lebaka
Senior Director, Clinical Data Management, Inspirna

11:30 AM

Advancements in AI: turning big data into actionable intel for optimal site identification

Despite advancing technologies, trials still struggle to meet patient enrolment goals. Slow enrollment directly impacts schedule and budget, with each day of delay carrying cripplingly high costs. Successful, timely patient recruitment is directly linked to effective site selection. Conversely, selecting the wrong site can negatively impact recruitment or result in total failure to enroll patients.  Join us to learn how advancements in AI can help the pharma industry identify the best sites for their clinical trials through the harnessing of big data. Topics include:

  • Transitioning from data overload to data driven decision-making
  • The role of Artificial Intelligence in optimizing site identification and selection
  • Expected and unexpected downstream benefits of an AI-enabled site selection strategy

Speakers

Travis Caudill
Vice President Feasibility, Site Identification & Clinical Informatics Feasibility & Site Identification Integration Workstream Lead, ICON

12 PM

FIRESIDE CHAT Are We Committed to Not Going Back?

Are We Committed to "Not Going Back"?

The rapid introduction of new approaches to sustain clinical trials during the COVID-19 pandemic drove substantial early enthusiasm that there was "no going back"

But with the convergence of the end of the pandemic along with a challenging economic environment, can we sustain this promise? How do we mitigate the risk of sliding backward and losing the positive changes introduced during the last two years?

  • Discuss the factors bringing new challenges to the adoption of innovative approaches in clinical trials
  • Explore how some organizations may be "over the crest" in change and adoption while others may "slide back"
  • Consider strategies to sustain forward momentum and progress despite new organizational challenges

Speakers

Craig H Lipset
Advisor and Founder, Clinical Innovation Partners
Hassan Kadhim
Senior Director, Head of Clinical Trial Business Capabilities, Bristol Myers Squibb

12:30 PM

The Digital-First Future of Clinical Trials

Technologies for life sciences were initially problem-solving solutions designed to streamline the management of clinical trials, speed up processes, and make data collection more accurate. Now, the industry is embracing a digital transformation enabled by widespread communication networks, proliferation of mobile devices, modern software approaches, and consumer industries.

 

Digital technologies are now viewed as solutions that can reduce site and patient burdens in clinical trials, improve access to trials, increase clinical trial diversity, and collect higher-quality data that can be used in more powerful ways to aid research.

 

In this session, we will discuss the importance of user-focused design when implementing digital health technologies such as eCOA, eConsent, telemedicine, wearables and more, to help create a better user experience and provide better quality data throughout a clinical trial.

Speakers

Donna M. Mongiello, RN, BSN
Senior VP, Strategic Solutions, YPrime
Joseph Im
Director, Digital Health Technologies Operations, Regeneron

1 PM

Lunch and networking

2 PM

Leveraging study participants’ Real-World Data to enable researchers to confirm the representativeness of the baseline

A patient enrols in a trial, is administered test drug, and has an outcome.  Post-treatment results are compared to pre-treatment to claim a change from baseline.  That is the classic method to establish a drug effect, whether it’s a positive treatment outcome or an adverse effect. But, this absolute dependence on the single baseline measurement may be unsubstantiated.

  • Looking at the reliability of baseline values
  • Leveraging real world data for that participant from their Electronic Medical Record

Speakers

Terry Katz
Sr. Director, Biostatistics and Data Management Planning and Functional Excellence, Daiichi Sankyo, Inc.

2:30 PM

Decentralization through Centralization: Thinking the Unthinkable in Clinical Trials

Decentralized clinical trials (DCTs) and centralized monitoring (CM) are two buzz words which appear contradictory to each other prima facie, bur are in fact very much symbiotic.
There is a consensus amongst most clinical trial stakeholders that DCTs are the future of clinical trials. It is a disruptive approach with immense potential to make clinical trials “Patient-centric”. However, as is true for any innovation, DCTs also comes with unique set of risks and require innovative monitoring model to mitigate the same.
DCTs collect data from multiple heterogenous sources and in high volumes which increases the risks related to data integrity, interpretation, and even patient safety.
The traditional method of 100% source data verification (SDV) is inefficient to match the speed and complexity of DCTs, which requires a more proactive and structured approach as provided by CM. The focus of CM is the critical data points and critical processes

which are likely to have maximum impact on data integrity. CM is concerned less with how the data looks like in an individual Case report Form (CRF), but more on the aggregated data through metadata driven harmonization across different modalities. Also, it can be much more proactive than traditional SDV. Hence, it will be wise to conclude that CM can provide the best required support for DCTs. Modern clinical trial implementation process and innovative digital solutions will be discussed to increase study access, reduce patient burden, improve data quality, integrity and management.

Speakers

Dr Atul Gupta, MD
Vice President, Medical Services and Client Solutions, Navitas life Sciences

2:45 PM

Running Up That Hill: Accelerate Cycle Times & Reach Patients Faster with elluminate

Operational oversight within outsourced models has become increasingly complex for teams who are tasked with managing trials amid a rapidly changing landscape of partners, technologies, and global regulations. Data proliferation along with dwindling resources has made it a top priority for clinical development teams to look to technology to improve cycle times and the overall experiences of data managers, medical monitors, and clinical operations leaders.

This presentation will highlight how the elluminate Clinical Data Cloud and Biometrics Services can reshape your data architecture by automating data flows to keep up with the pace of data evolution and speed time to insights.

Learn how elluminate and eClinical’s Biometrics Services deliver:

  • Operational insights across numerous data sources that provides definitive answers and analytics on enrollment, protocol compliance and safety
  • Improved study oversight with a holistic view of risk across all data sources
  • 50 out-of-the-box visualizations to support supports cross-study analysis for deeper insights with self-service access to clinical and operational analytics
  • Increased productivity across data management, medical monitoring, clinical operations, clinical programming and statistical analysis roles

Speakers

Jason Konn
Solution Consultant, eClinical Solutions

3 PM

FIRESIDE CHAT: Clinical Trials. What the Changing Social, Political and Economic Landscape Means for Evidence

The US and countries around the globe are in the midst of shifts in their demographic and political systems.  This has significant implications for developing and applying evidence. Research systems, clinical trial recruitment and retention, and even data analysis must change to ensure new technologies and therapeutics are effective for as many people as possible. This fireside chat will explore several important questions:

 

  • Is diversity in clinical trials possible?
  • What diversity practices can be applied to clinical trials in order to operate smoothly and within budget?
  • What are the consequences of leaving people out?
  • How can we ensure that newly created evidence is applicable for everyone?

Moderator: Rosalie Filling, Vice President, Clinical Operations & Biometrics, Endo Pharmaceuticals

Speakers

Linda Blount
President, The Black Women's Health Imperative

3:30 PM

Afternoon refreshments, networking and Apple prize draw

4 PM

Featured New Technology Presentation: Administration of Respiratory Therapeutics with a Device and Fixed Dose Drug Combination Using Portable Medical Vaporizers

  • First usage of Portable Therapeutic Vaporizers as a new delivery modality for prescription drugs arising out of technologies originally developed as electronic nicotine delivery systems (ENDS)
  • Advantages in safety and efficacy of delivering respiratory drug regimens directly to sinus, throat and lung tissue in gas vapor form
  • Likely regulation of a new therapeutic delivery modality
  • Clinical trial challenges for therapeutic vape device and drug systems

Speakers

John Gregg
Chairman and CEO at BalinBac Therapeutics, Inc.

4:30 PM

Hybrid trials using DCT technology and processes; focus on patients and the sites

  • Highlighting the complexity that Hybrid/DCT brings whilst moving away from the common brick-and-mortar sites.
  • Discussing the rise in regulator concerns in areas such as investigator oversight, and participant’s safety when face to face contact is limited.
  • How we tend to focus too much on technology when it’s actually the processes for the patients and the sites that matter even more.
  • Major points to consider in designing hybrid/DCT trials; building blocks and practical examples to best prepare you to meet the needs of regulators whilst keeping the patient and sites front of mind.

Speakers

Streams

Stream one

Outsourcing and Clinical Operations

Stream two

Clinical Innovation & Technology

8:15 AM

Registration and Refreshments

9 AM

What does it really take to achieve global IDEA in clinical trials?

  • Inclusion, Diversity, Equity, and Access
  • Major barriers to achieving IDEA for sponsors and investigator teams
  • Recent regulatory guidelines
  • Strategies for achieving IDEA in clinical trials

Speakers

Harsha K Rajasimha, Ph.D.
Founder and Executive Chairman, Indo US Organization for Rare Diseases (IndoUSrare)

9:30 AM

Work smarter, not harder: Fulfilling your cardiac safety requirements without a Thorough QT (TQT) study

  • Recent updates to the ICH guidance enable several pathways to a TQT waiver
  • High quality ECG data in phase I can enable early decision making
  • Save time and substantial cost compared to a dedicated TQT study
  • Not just for oncology; applicable for all TAs

Speakers

Todd Rudo, MD
EVP & Chief Medical Officer, Clario

10 AM

Interactive Session: The Elephant in the room – what is holding you back from developing key relationships when managing your trials? Are you in your own way?

How do you relate and interact with:

  • Your Study Team
  • Your Vendors
  • Your Manager
  • Yourself
  • Are you willing to face others’ perceptions of you?

This will be a brief presentation followed by an Open discussion on some barriers to communication that Clinical Operations professional experience.

Speakers

Jenny Wakefield
Senior Director- Quality Development Operations, Incyte

10:30 AM

Morning refreshments and networking

11 AM

Population Health & Diversity in Clinical Trials

  • Highlighting the importance of inclusion
  • Focusing on the opportunities within Decentralised Clinical Trials to encourage enhanced enrolment of minority and diverse populations into research
  • Understanding why we struggle to recruit a varied patient population; how improving our recruitment can improve our study results
  • Looking into the best step forward

Speakers

Ram Raju
Senior Vice President and Community Health Investment Officer, Northwell Health

11:30 AM

Outsourcing independent committees: benefits, operational considerations, and best practices

From mitigating risk to ensuring independent expert committee success, proper management and setup is crucial. During this session, we will discuss outsourcing independent committees, industry best practices, and operational strategies that drive meaningful results.

Speakers

David Cutler
Director, Project Management, WCG

12 PM

PANEL DISCUSSION: What are the different outsourcing relationships and how do you manage them?

  • What are the categories and the driving needs for 2023?
  • How has this changed over the years?
  • Key strategies that sponsor companies have – how has this changed?
  • Did the pandemic effect these strategies?

 

Speakers

Rosalie Filling
Vice President, Senior Global Head R&D Operations, Endo Pharmaceuticals
Kevin Shipe
Director, Head of Strategic Sourcing and Study Start-up, INOVIO Pharmaceuticals
Adam Barrows
Executive Director - Solid Tumour TA Head, Bristol Myers Squibb
Sherin Abdel-Meguid
President, Shifa Biomedical Corporation
Lauren Colfer
Former Vice President, Clinical Operations at Aceragen Pharmaceuticals

12:45 PM

Lunch and Networking

1:45 PM

Collaborating across Functions to Improve the Forecasting, Budgeting, and Accruals Process

This fireside chat will focus on the accrual/forecasting process for Clinical trial budgets. Specifically, the processes for working with vendors to obtain current accruals and forecasts. We will also discuss coordination with the internal functions at the Sponsor to ascertain the most accurate and current timelines, enrollment rates, screen failure and drop out rates. Aligning all expectations with both the operations teams as well as Finance and Senior Management.

Speakers

Carrie Lewis
Executive Director, Clinical Program Optimization, Endo Pharmaceuticals
Rick O’Hara
Director of R&D Business Operations, Endo Pharmaceuticals

2:15 PM

PANEL DISCUSSION: Diversity & Inclusion in Clinical Trials

  • Increasing diversity in clinical trials; overcoming critical barriers
  • Focusing on the application of diverse populations
  • Action for increasing diversity
  • Regulatory Updates

Speakers

Linda Blount
President, The Black Women's Health Imperative
Jenifer Waldrop
Executive Director, Rare Disease Diversity Coalition
Harsha K Rajasimha, Ph.D.
Founder and Executive Chairman, Indo US Organization for Rare Diseases (IndoUSrare)
Jen Horonjeff
CEO, Savvy Cooperative
Ram Raju
Senior Vice President and Community Health Investment Officer, Northwell Health

3 PM

Afternoon refreshments and Apple prize draw

3:30 PM

ROUNDTABLE SESSIONS

During the roundtable discussion session, the conference hall will be divided into zones. Delegates can choose which zone they would like to join. Each zone will be led by a table moderator and will focus on a different challenge within the industry. After 30 minutes, delegates will have the opportunity to swap and choose a different table, and each roundtable will run twice.

Roundtable 1 - Strategies for Country and Site Selection 

Kelly Ragins, Global Head of Portfolio Delivery Office, Novartis

Roundtable 2 Implementing effective vendor management tools and communication strategies to avoid the failure of clinical trials 

Kathleen Cohen, Head of Clinical Operations, Marinus Pharma

Roundtable 3 Top Tips in Effective Budget Management, Forecasting and Contracting: Ensuring Your Resources Are Allocated Correctly 

Kevin Shipe, Director, Head of Strategic Sourcing and Study Start-up, INOVIO Pharmaceuticals

Roundtable 4 Decentralised Clinical Trials; a discussion on transforming clinical trial development

Candice Estes, Clinical Trial Manager, Clinical Operations, Incyte

Roundtable 5 Discussing intersections with rare diseases, health disparities and clinical trial research

Jenifer Waldrop, Executive Director, Rare Disease Diversity Coalition

Speakers

Kelly Ragins
Global Head of Portfolio Delivery Office, Novartis
Kathleen Cohen
Head of Clinical Operations, Marinus Pharma
Kevin Shipe
Director, Head of Strategic Sourcing and Study Start-up, INOVIO Pharmaceuticals
Candice Estes
Clinical Trial Manager, Clinical Operations, Incyte
Jenifer Waldrop
Executive Director, Rare Disease Diversity Coalition

4:30 PM

Chairman’s closing remarks

END OF DAY TWO

9 AM

Digital and telehealth; remote monitoring in clinical trials

  • Integrating apps and wearables into your clinical study: what additional benefits can this bring?
  • Combining remote monitoring with risk-based monitoring to deliver a successful decentralised trial
  • How consumer-wearables can provide enhanced access to clinical trials
  • Compiling data from wearables to contribute toward clinical trials
  • Overcoming common issues around using data collected remotely

Speakers

Jen Horonjeff
CEO, Savvy Cooperative

9:30 AM

From Concept to Breakthrough: The Case for AI/ML in Clinical Development

The industry is facing significant challenges finding the right resources to deliver operational best practices. There is also an expectation to move at the “speed of Covid” for every trial. It feels like an either/or.

 However, you can have both. You can accelerate times with fewer resources - by applying artificial intelligence (AI) and machine learning (ML) to key clinical development processes.

 Join this exciting session to learn how you can use AI/ML - and other advanced technologies - to:

  • Centralize and standardize your trial data
  • Accelerate the data review and cleaning process
  • Understand how patients are responding to treatment
  • Prevent early withdrawals, screen failures, and even potential adverse events
  • Automate raw data transformation for regulatory submissions

Speakers

Ted Kirby
Senior Director, Product Marketing, Saama

10 AM

Blockchain comes before Artificial Intelligence – Exploring the Implications for the Future In this session Frank Leu, CEO at BioPharMatrix explores where he sees Blockchain going in the future, its implications and whether we should all be investing in it.

  • What is blockchain?
  • How can it be adapted in the Clinical Trial?
  • Why do we need to reach a consensus platform as soon as possible?  Who gets to decide this, will it be FDA or the Pharma industry?
  • What would be its cost impact on drug development?
  • Why does the C-suite need to engage in blockchain use immediately?

Speakers

Frank Leu
CEO, BioPharMatrix

10:30 AM

Morning Refreshments & Networking

11 AM

Fireside Chat: Leveraging global trial footprint to accelerate clinical development

Clinical trial conduct is facing multiple challenges from budget pressure, patient recruitment difficulties, to regulatory uncertainties. At the beginning of each development program, companies need to plan for global trial capabilities by utilizing multiple geographic locations for clinical trials to accelerate the development process. This approach allows for larger and more diverse patient populations to be enrolled, leading to faster completion of trials and ultimately getting treatments to market faster. A global trial footprint also enables the collection of data in different regions and across different populations, providing valuable insights into the efficacy and safety of treatments. By leveraging a global trial footprint, biotech and pharmaceutical companies can overcome barriers to clinical development and bring life-saving treatments to patients more quickly.

Speakers

YuFeng Li
Executive Director, Clinical Development Qilu Pharmaceuticals
Will Newton
Senior Healthcare Reporter, Clinical Trials Arena, GlobalData Healthcare

11:30 AM

Leveraging predictive analytics to improve patient retention, data quality, and enrollment outcomes in clinical trials

Clinical trial data complexity has tripled in the past decade, leading to fragmented data, insights, and stakeholder collaboration. These data complexities pose significant inefficiencies in the research and drug development process and are exacerbated as clinical operations teams become leaner and cost-constrained. 

In this presentation, you will gain insight to real world case studies that use Lokavant to radically improve clinical trial outcomes, as well as overall successes for leaner study teams.

Speakers

Rohit Nambisan
CEO & Co-Founder, Lokavant

12 PM

PANEL: Addressing the issues with Decentralised Clinical Trials and how we may work collaboratively to overcome them; addressing the pitfalls & challenges

  • There are varied viewpoints on the success of DCT’s, we are therefore using this panel as a platform to discuss issues raised within processes
  • Are timelines actually increasing? Taking into consideration site staff turnover and knowledge base
  • It is said DCT’s will enhance patient recruitment, is this the truth in practice? Looking into patient’s ability to par-take and keep to trial timelines considering factors beyond our control
  • Site Perspective; their involvement with sponsors and the differences with their involvement of the trial

Moderator: Peter O'Neill, Senior Director, Clinical Operations, Cellectis
Panelists:
Anka G. Ehrhardt, Director, Cell-Based Sciences, AR&D, Merck
Dominique Duchesne, VP Global Head of Clinical Operations, Ichnos Sciences

Speakers

Peter O’Neill
Senior Director, Clinical Operations, Cellectis
Anka G. Ehrhardt
Director, Cell-Based Sciences, AR&D, Merck
Dominique Duchesne
VP Global Head of Clinical Operations, Ichnos Sciences
Susan Maloney
Former Associate Vice President, Head Clinical Operations, PhaseBio
Keith Kennedy
Principal and Team Lead, Patient Cloud, Medidata
Candice Estes
Clinical Trial Manager, Clinical Operations, Incyte

2023 Speakers

Select a speaker to learn more

Back
Craig H Lipset
Advisor and Founder, Clinical Innovation Partners

Co-Chair, Decentralized Trials & Research Alliance

Adjunct Assistant Professor, Rutgers University

Vice President, Foundation for Sarcoidosis Research

Craig Lipset is an advisor, educator, advocate, and innovator focused on novel solutions for clinical trials and medicine development. He is the founder of Clinical Innovation Partners, providing advisory and board leadership with pharma, tech, and investors.  Craig is Co-Chair for the Decentralized Trials & Research Alliance and Vice President of the Foundation for Sarcoidosis.  He is Adjunct Assistant Professor in Health Informatics at Rutgers University and serves on the Advisory Council for HL7 Project Vulcan and External Stakeholder Board for IMI Trials at Home.

 

Craig was previously the Head of Clinical Innovation and Venture Partner at Pfizer, and on the founding management teams for two successful startup ventures.

Session Details:

Keynote We Are All At-Risk of Being Obsolete: Earning Our Place in the Future of Clinical Research

2023-05-23, 8:30 AM

Session Details:

FIRESIDE CHAT Are We Committed to Not Going Back?

2023-05-23, 12:00 PM

View In Agenda
Next speaker
Back
Rosalie Filling
Vice President, Senior Global Head R&D Operations, Endo Pharmaceuticals

In her over 25 years of experience, Rosalie “Rosie” Filling has transformed R&D operations in every company she has worked for, developing clear-cut strategies to help advance clinical trials with high-quality operational execution and scientific excellence.

 

Rosie is the Vice President, Senior Global Head R&D Operations Endo International plc. She is part of the global R&D leadership team and is charged with the coordination and implementation of clinical development strategies for the company’s research and development. She provides strategic direction and oversight of the R&D Operations team, which includes clinical operations, data management, biostatistics, medical writing, clinical supplies, trial master file/inspection readiness and business operations. This integrated team handles the execution of all aspects related to Endo’s clinical trials. Endo has active research and development programs in men’s health, orthopedics, and endocrinology. Beyond these therapeutic areas, the company also has focused development in the areas of sterile injectables and complex generic products.

 

Rosie’s main focus at all times is on the end users—the patients. Bringing new and, at times, life-saving medications to patients drives Rosie’s sense of purpose.

 

Rosie joined Endo from Lupin Pharmaceuticals in Blue Bell, PA where she was Senior Director, Head of Clinical Operations, and built the clinical operations organization to support the US and Global R&D Organization. Prior to Lupin, Rosie spent nearly five years at Teva in Frazer, PA where she was the US site head of Clinical Operations and was responsible for the successful delivery of Inhalation, Women’s Health, and Cardiovascular clinical trials. Earlier in her career, Rosie held various roles at Eisai, MGI Pharma and PPD.

 

Rosie earned her B.S. in Biology with a minor in Chemistry from the University of Pittsburgh.

Session Details:

Panel: Reversing the Conversation: What the clinical trial industry really wants from its service providers

2023-05-23, 12:00 PM

Session Details:

PANEL DISCUSSION: What are the different outsourcing relationships and how do you manage them?

2023-05-24, 12:00 PM

View In Agenda
Next speaker
Back
Peter O’Neill
Senior Director, Clinical Operations, Cellectis

"Work Hard, Stay Calm, and Cure Cancer! This is Peter O'Neill's motto while conducting oncology clinical trials at Cellectis, where he is Senior Director of Clinical Operations. Peter was named to PharmExec’s list of "2020 Emerging Pharma Leaders” and has been conducting clinical trials for over 24 years, formerly at Incyte, Sanofi, and Beth Israel Deaconess Medical Center. He is passionate about developing new therapies for patients, with a focus on innovative strategies to enhance the clinical trial experience for participants, caregivers, and care teams.

Session Details:

Chairperson’s opening remarks

2023-05-23, 8:20 AM

Session Details:

PANEL: Addressing the issues with Decentralised Clinical Trials and how we may work collaboratively to overcome them; addressing the pitfalls & challenges

2023-05-24, 12:00 PM

View In Agenda
Next speaker
Back
John Gregg
Chairman and CEO at BalinBac Therapeutics, Inc.

John Gregg, Pharmaceutical industry executive, John Gregg, has extensive experience in worldwide clinical development and commercialization of new anti-infective drugs. He has spent much of his career in senior roles directing the development and commercialization efforts for a large number of antibiotic, anti-protozoal, anti-fungal and anti-viral drugs. He is a veteran of new product development leadership positions at Pfizer, Novartis, J&J, BMS, and more recently his start-ups, Symbiomix Therapeutics, LifeQual Pharmaceuticals, and AkaRx. He is now the CEO of a BalinBac Therapeutics, Inc., a specialty infectious disease and microbiome modulation company. He was trained as a microbiologist and has led multi-disciplinary anti-infective drug development teams at the largest pharmaceutical companies, as well as small, private specialty firms directing the work of colleagues and contract laboratories

Session Details:

Featured New Technology Presentation: Administration of Respiratory Therapeutics with a Device and Fixed Dose Drug Combination Using Portable Medical Vaporizers

2023-05-23, 4:00 PM

View In Agenda
Next speaker
Back
Harsha K Rajasimha, Ph.D.
Founder and Executive Chairman, Indo US Organization for Rare Diseases (IndoUSrare)

Session Details:

What does it really take to achieve global IDEA in clinical trials?

2023-05-24, 9:00 AM

Session Details:

PANEL DISCUSSION: Diversity & Inclusion in Clinical Trials

2023-05-24, 2:15 PM

View In Agenda
Next speaker
Back
Jill McNair
Chief Growth Officer, CISCRP

Jill has worked in the industry for over 25 years. She is the Chief Growth Officer at the Center for Information and Study on Clinical Research Participation (CISCRP) where she has worked since 2007. I joined CISCRP in 2007 to advance our mission to inform and empower patients and the public as partners in clinical research. Throughout my tenure, I have led a variety of teams and functions in delivering on our mission and advocating for public health literacy, patient education and engagement.

In my new role as Chief Growth Officer, I focus on nurturing our established relationships, building new ones, and on identifying and developing new opportunities. As a non-profit innovator, CISCRP is uniquely positioned to serve patient communities and clinical research stakeholders throughout the world with the highest quality educational and advocacy services. I’m so excited about the trajectory of CISCRP’s growth and welcome the opportunity to nurture current and new relationships and collaborations.

As a non-profit innovator, Jill serves patient communities and clinical research stakeholders throughout the world with the highest quality educational and advocacy services.

Jill received her MBA from the Fox School of Business at Temple University, and she resides in Bucks County, PA with her husband, three children and three dogs.

Session Details:

Encouraging public health literacy, patient education and engagement; informing and empowering patients and the public as partners in clinical research

2023-05-23, 3:00 PM

View In Agenda
Next speaker
Back
Narayan Lebaka
Senior Director, Clinical Data Management, Inspirna

Narayan has and ten (10)+ years of award-winning and progressive experience delivering the highest standards of clinical data management at Bayer and Bristol Myers Squibb (BMS). Bayer Gold Award 2017, Bronze Award 2016, and Pinnacle Award 2015; BMS Performance Award. In-depth knowledge of all aspects of clinical data management, reporting, reconciliation, study reviews, and standards development that drive pharmaceutical businesses forward. 

Session Details:

Data Management in Oncology; the importance of using suitable technology in your clinical trial, leading to a manageable data structure

2023-05-23, 11:00 AM

View In Agenda
Next speaker
Back
Rick O’Hara
Director of R&D Business Operations, Endo Pharmaceuticals

Session Details:

Collaborating across Functions to Improve the Forecasting, Budgeting, and Accruals Process

2023-05-24, 1:45 PM

View In Agenda
Next speaker
Back
Anthony Fuller
Global Head of Sourcing, Mitsubishi Tanabe Pharma Development America

Passionate sustainability and procurement leader with the mission to put ESG at the heart of all supplier relationships. 15+ years' senior level experience, driving strategic partnerships and embedding sustainability goals into supply network. Collaboration catalyst, initiative builder, and speaker, I put responsible sourcing front and center in business and procurement strategy.

Session Details:

Protecting our planet: Sustainable drug development

2023-05-23, 2:00 PM

View In Agenda
Next speaker
Back
Ram Raju
Senior Vice President and Community Health Investment Officer, Northwell Health

Dr. Ram Raju has a distinguished career over 40 years as a healthcare provider, teacher, researcher and community organizer. In his role at Northwell Health, Dr. Raju set the strategic vision to improve population health by finding ways to meet the needs of its most vulnerable communities, by examining the existing programs aimed at improving the health system's response to the community's needs and working with local organizations to address them. Northwell Health is the largest healthcare provider in the state of New York, is a system with 23 hospitals and 830 outpatient facilities that sees 2 million people every year in the New York metro area and beyond.

Session Details:

PANEL DISCUSSION: Diversity & Inclusion in Clinical Trials

2023-05-24, 2:15 PM

Session Details:

Population Health & Diversity in Clinical Trials

2023-05-24, 11:00 AM

View In Agenda
Next speaker
Back
Frank Leu
CEO, BioPharMatrix

Session Details:

Blockchain comes before Artificial Intelligence – Exploring the Implications for the Future In this session Frank Leu, CEO at BioPharMatrix explores where he sees Blockchain going in the future, its implications and whether we should all be investing in it.

2023-05-24, 10:00 AM

View In Agenda
Next speaker
Back
Carrie Lewis
Executive Director, Clinical Program Optimization, Endo Pharmaceuticals

Carrie Lewis has close to 20 years of varied Clinical Research experience.  Carrie is currently an Executive Director, Clinical Program Optimization at Endo Pharmaceuticals where she oversees Clinical Operations (Phase 2-4) as well Business Operations, eTMF/inspectional readiness, and Training/Oversight.  Prior to Endo, Carrie garnered extensive knowledge in many roles while in academia, at large sponsors, generic sponsor, as well as a global CRO.  She has a master’s degree in Clinical Research Administration and has experience in multiple therapeutic

Session Details:

Collaborating across Functions to Improve the Forecasting, Budgeting, and Accruals Process

2023-05-24, 1:45 PM

View In Agenda
Next speaker
Back
Adam Barrows
Executive Director - Solid Tumour TA Head, Bristol Myers Squibb

Adam joined Bristol Myers Squibb in 2016 and has held various roles in Oncology Clinical Protocol Operations, Oncology Clinical Development and Global Clinical Trial Strategy & Operations.  Adam is currently the Global Development Operations Therapeutic Area Head for Solid Tumor Oncology leading a team of Operation Portfolio Leads with Full Development.  Before joining BMS, Adam worked for several other sponsors (Wyeth, Merck) and CRO partners across all phases of development and multiple indications including Metabolism, cardiovascular, CNS and Oncology.   Having started his clinical career as a Clinical Nurse Assistant he built upon this experience at the patient bedside and started in industry with a role in data management but has spent the bulk of his time in clinical trial management (project and portfolio management).  Adam holds his Bachelor of Science in Biology and French and a Master of Business Administration.  Adam lives in Pennsylvania, with his wife, Marci, and two children, Vivienne and Oliver.  He is an avid morning runner and usually starts his day with a few miles run and the obligatory few cups of coffee.

Session Details:

How CRO’s can help sponsors be the sponsor of choice, a partnership with CRO’s population of sites and conducting clinical trials

2023-05-23, 4:00 PM

Session Details:

PANEL DISCUSSION: What are the different outsourcing relationships and how do you manage them?

2023-05-24, 12:00 PM

View In Agenda
Next speaker
Back
Kathleen Cohen
Head of Clinical Operations, Marinus Pharma

Kathleen Frenia Cohen is Vice President and Head of Clinical Development Operations at Marinus Pharmaceuticals.  Prior to joining Marinus, she spent 20+ years at PRA Health Sciences in a variety of project management and operational oversite roles. Kathleen graduated from the University of the Science in Philadelphia with a PharmD and completed a post-doctoral fellowship in Pharmacoeconomics and Outcomes Research from Rutgers College of Pharmacy. Kathleen resides in Media, PA.

Session Details:

Panel: Reversing the Conversation: What the clinical trial industry really wants from its service providers

2023-05-23, 12:00 PM

Session Details:

ROUNDTABLE SESSIONS

2023-05-24, 3:30 PM

View In Agenda
Next speaker
Back
Ella Balasa
Patient Advocate, speaker, published writer, and health engagement consultant

Ella Balasa is a patient advocate, consultant, and a person living with cystic fibrosis. She has committed her time to empowering patients and advancing healthcare strategies. She speaks publicly about the value of patient perspective and has a passion for distilling clinical information for patient communities. Through opportunities working with healthcare organizations on content strategy, writing, speaking, clinical trial development, and sharing the patient experience she aims to affect the healthcare landscape by raising awareness of rare diseases, promoting self-advocacy to patients, and valuable insights to organizations. More of her work and experiences can be found at www.ellabalasa.com.

Session Details:

Strengthening patient relationships authentically to enhance the therapeutic development process

2023-05-23, 11:00 AM

View In Agenda
Next speaker
Back
Kelly Ragins
Global Head of Portfolio Delivery Office, Novartis

Session Details:

ROUNDTABLE SESSIONS

2023-05-24, 3:30 PM

View In Agenda
Next speaker
Back
Anka G. Ehrhardt
Director, Cell-Based Sciences, AR&D, Merck

Dr. Ehrhardt is a biophysicist with a Ph.D. in human physiology. Throughout her career, she focused on driving biomedical research through efficient application of innovative technologies and strategies. She built and led successful teams in industry, including at Merck, where she headed a laboratory providing leading technologies for cell-based research from early discovery through manufacturing; and at BMS where Dr. Ehrhardt led and grew an international clinical assay team to robustly cover large scale registrational and translational clinical analysis generating clinical decision-driving data and mechanistic insights for immuno-oncology, cardiovascular, immunology, metabolic and rare disease studies. Before returning to Merck, Dr. Ehrhardt fulfilled one of her scientific aspirations at CHDI Foundation, designing and implementing successful clinical biomarker discovery and development strategies for Huntington’s disease. Currently, at Merck, Dr. Ehrhardt is providing strategic and technical leadership for the development and implementation of industry-leading and QC-friendly cell-based assays and models for potency determination that reflect the unique mechanisms of biologics products in clinical studies and beyond.

Session Details:

PANEL: Addressing the issues with Decentralised Clinical Trials and how we may work collaboratively to overcome them; addressing the pitfalls & challenges

2023-05-24, 12:00 PM

View In Agenda
Next speaker
Back
Venkat Sethuraman, Ph.D MBA
Head of Global Biometrics and Data Sciences, Bristol Myers Squibb

Venkat Sethuraman is currently the Global Head of Biometrics and Data Sciences at Bristol Myers Squibb, where he is accountable for the biostatistics/quantitative support to R&D Global Development and Medical organization. In addition, Venkat leads the Innovation Pillar for the Global Drug Development.

Prior to BMS, Venkat was a partner at a management consulting firm, where he led the R&D clinical development and operations. While there, he worked closely with R&D leaders of top 10 pharma companies in driving data-driven clinical decision-making, leveraging advanced analytics and data science. Venkat has held various leadership roles at BMS, Novartis Oncology and GSK leading quantitative and biometrics organization. Venkat has diverse research interests and consulting experience in industry that includes clinical trials design, innovative trial models, data science, and most recently, digital efforts in clinical research.

Venkat received a PhD in statistics from Temple University and an MBA from the Wharton School of the University of Pennsylvania. He currently serves on the Board of Association for Women in Science (AWIS) and has served on the board of the Biopharmaceutical Section of the American Statistical Association.

 

Session Details:

Artificial Intelligence & the future of clinical trials: the potential of AI to help with study planning

2023-05-23, 9:30 AM

View In Agenda
Next speaker
Back
Adam Kinsey
Associate Vice President, Global Clinical Trial Operations (GCTO), Head of GCTO North America, Merck Novotech

Adam Kinsey is currently Associate Vice President and Regional Head of North America for Global Clinical Trial Operations (GCTO) at Merck Research Laboratories. He has over 25 years of clinical research experience, with the last 8 at Merck. He has been a key leader within GCTO, most recently serving as Executive Director, GCTO Clinical Sciences & Study Management (CSSM) and Therapeutic Area Section (TAS) Head: Melanoma, Hepatobiliary Cancers, and Innovative Strategies. Previously, Adam was Clinical Research Director (CRD) Oncology where he served as Director of country clinical operations activities in the United States for Merck’s oncology pipeline. Adam started his career as a CRA and has traversed through various roles in clinical operations of increasing responsibility and scope. He also has experience across a wide array of therapeutic areas and with companies of different sizes and operating models. Adam has a bachelor’s degree in biology from Rice University in Houston. He completed post-baccalaureate course work at Houston Baptist University and coursework toward a Master of Public Health (MPH) degree at the University of Texas School of Public Health in Houston.

Session Details:

Panel: Reversing the Conversation: What the clinical trial industry really wants from its service providers

2023-05-23, 12:00 PM

View In Agenda
Next speaker
Back
Susan Maloney
Former Associate Vice President, Head Clinical Operations, PhaseBio

Session Details:

PANEL: Addressing the issues with Decentralised Clinical Trials and how we may work collaboratively to overcome them; addressing the pitfalls & challenges

2023-05-24, 12:00 PM

View In Agenda
Next speaker
Back
Linda Blount
President, The Black Women's Health Imperative

Linda Goler Blount, MPH, is the President and CEO of the Black Women’s Health Imperative, the only national organization focused on Black women’s emotional, physical and financial health. Since joining the organization in 2014, Ms. Blount has overseen more than $20 million invested in Black women and research to prevent chronic disease and HIV, ensure reproductive justice and healthy maternal outcomes, and advocate for health promoting policies. Ms. Blount, an epidemiologist, edited IndexUS, the first research on Black women’s health based on healthy Black women. Her career includes successful tenures at CDC, the Coca-Cola Company and consulting with health ministries in countries in Europe, Africa and the Caribbean.

Session Details:

FIRESIDE CHAT: Clinical Trials. What the Changing Social, Political and Economic Landscape Means for Evidence

2023-05-23, 3:00 PM

Session Details:

PANEL DISCUSSION: Diversity & Inclusion in Clinical Trials

2023-05-24, 2:15 PM

View In Agenda
Next speaker
Back
Jenifer Waldrop
Executive Director, Rare Disease Diversity Coalition

Jenifer Ngo Waldrop joined the Black Women’s Health Imperative (BWHI) as Executive Director of the Rare Disease Diversity Coalition (RDDC) in October 2022. Before joining the leadership team of RDDC, she developed models and programs for diversity, equity, and inclusion initiatives to support multiple business units with Fortune 500 companies and organizations in Asia, Canada, and the US.

Jenifer has led initiatives at non-profit organizations where she recruited local community members to participate in numerous health-related fundraising events and developed programs to target disparities and underrepresented groups. In addition to facilitating development and fundraising, Jenifer developed a reputation for successful coalition building.

Jenifer received her undergraduate degree from Colby College and her Master of Human Resources Development from Villanova. As the Professional Development Director of the National Association of Asian-American Professionals (NAAAP) of Colorado, Jenifer continues her outreach in society. Through this organization, she mentors formally and informally.

Session Details:

ROUNDTABLE SESSIONS

2023-05-24, 3:30 PM

Session Details:

PANEL DISCUSSION: Diversity & Inclusion in Clinical Trials

2023-05-24, 2:15 PM

View In Agenda
Next speaker
Back
Evan Tzanis
Chief Operating Officer and Executive Vice President, Head of R&D, Neuraptive Therapeutics
Next speaker
Back
Dominique Duchesne
VP Global Head of Clinical Operations, Ichnos Sciences

Dynamic leader in clinical operations with over 25 years of experience across various therapeutics areas.  After obtaining her master's degree in microbiology and immunology from a Canadian university, she joined the pharmaceutical industry where she held positions of increasing responsibility, most recently leading the clinical operations team at a small biotech company.  She has worked on programs in all phases of clinical development, in small and large organizations, and is recognized for building highly successful teams.  Her focus is providing guidance and removing obstacles to enable the team to execute efficiently while maintaining a strong sense of teamwork and enthusiasm.  She is passionate about helping others grow and develop and places a high priority on working with the members of her team to achieve their goals.

Session Details:

PANEL: Addressing the issues with Decentralised Clinical Trials and how we may work collaboratively to overcome them; addressing the pitfalls & challenges

2023-05-24, 12:00 PM

View In Agenda
Next speaker
Back
Kevin Shipe
Director, Head of Strategic Sourcing and Study Start-up, INOVIO Pharmaceuticals

Session Details:

ROUNDTABLE SESSIONS

2023-05-24, 3:30 PM

Session Details:

PANEL DISCUSSION: What are the different outsourcing relationships and how do you manage them?

2023-05-24, 12:00 PM

View In Agenda
Next speaker
Back
Jen Horonjeff
CEO, Savvy Cooperative

Jen Horonjeff, PhD, is a patient advocate and the Founder & CEO of Savvy Cooperative. She was named one of the 50 Most Daring Entrepreneurs by Entrepreneur Magazine, alongside Elon Musk and Reese Witherspoon, for her work at Savvy, which helps companies equitably gather input and insights from diverse patients. Jen is passionate about patient co-design as she grew up with juvenile idiopathic arthritis, and survived a brain tumor as an adult. She also holds a PhD in Environmental Medicine, and previously worked as a health outcomes researcher, a human factors engineer and user-centered designer, and an advisor to the FDA. Jen serves on the Board of Directors for The Sequoia Project, a non-profit focused on health data exchange, the Advisory Board of Trialbee, a clinical trial recruitment company, and numerous other committees to ensure the patient voice is included.

Session Details:

Digital and telehealth; remote monitoring in clinical trials

2023-05-24, 9:00 AM

Session Details:

PANEL DISCUSSION: Diversity & Inclusion in Clinical Trials

2023-05-24, 2:15 PM

View In Agenda
Next speaker
Back
Jenny Wakefield
Senior Director- Quality Development Operations, Incyte

Jenny Wakefield is an Adult and Pediatric Oncology and Critical Care Registered Nurse, ACRP-CP and CCRA Certified. Jenny graduated with her BSN from Florida International University in Miami, Florida, and has worked in Clinical Research since 1997 in a variety of roles, at the Site, CRO and Sponsor levels in all Phases of Global Clinical Trials and multiple disease indications. With her diverse experience, Ms. Wakefield brings a unique level of insight to the challenges faced in the management of Clinical Trials. Jenny currently is the Senior Director of Quality and Clinical Operations at Incyte. Ms. Wakefield’s specific focus is delivering Quality Programs with a humanistic approach, blending what’s expected from Clinical Research Professionals with what the real world presents.

Session Details:

Interactive Session: The Elephant in the room – what is holding you back from developing key relationships when managing your trials? Are you in your own way?

2023-05-24, 10:00 AM

View In Agenda
Next speaker
Back
Sherin Abdel-Meguid
President, Shifa Biomedical Corporation

Dr. Abdel-Meguid has extensive experience in drug discovery. He built and managed a number of successful departments and drug discovery programs. He founded Shifa Biomedical Corporation (Shifa), a company dedicated to the treatment of cardiovascular diseases. He also founded ProXyChem, a company focused on providing drug discovery solutions to the biotech and pharmaceutical sector. Prior to this, he was Chief Scientific Officer and Co-Founder of Suntory Pharmaceutical Research Laboratories (SPRL), a structure-based drug discovery company dedicated to the treatment of cardiovascular and immune disorders. Before the formation of SPRL, he was Worldwide Director of Structural Biology and Director of Macromolecular Sciences at SmithKline Beecham (SB), now Glaxo SmithKline (GSK). He also served as Director of several therapeutic programs. Prior to SB, he was head of Biophysical Sciences and Protein Engineering at Monsanto. He has a PhD in Physical Chemistry and MS and BS in Biochemistry.

Session Details:

PANEL DISCUSSION: What are the different outsourcing relationships and how do you manage them?

2023-05-24, 12:00 PM

View In Agenda
Next speaker
Back
Candice Estes
Clinical Trial Manager, Clinical Operations, Incyte

Candice Estes is as a Clinical Trial Manager at Incyte and works extensively in the decentralized trial space. She holds her Masters of Public Health in Epidemiology from the University of Alabama at Birmingham and has worked in Clinical Research since 2013 in a variety of roles including a Data Manager, Biostatistician, Oncology Research Coordinator, Clinical Trials Specialist and multiple levels of Clinical Research Associate. Ms. Estes’ specific focus lies in pushing dermatologic products forward, bridging the gap between clinical operations and global monitoring and operationalizing decentralized trials.

Session Details:

ROUNDTABLE SESSIONS

2023-05-24, 3:30 PM

Session Details:

PANEL: Addressing the issues with Decentralised Clinical Trials and how we may work collaboratively to overcome them; addressing the pitfalls & challenges

2023-05-24, 12:00 PM

View In Agenda
Next speaker
Back
Hassan Kadhim
Senior Director, Head of Clinical Trial Business Capabilities, Bristol Myers Squibb

Multilingual professional with 15+ years experience with informatics & digital technology in the pharmaceutical / biotechnology industry. With university degrees in Bioinformatics and in Clinical R&D, Hassan has a great mix of pharmaceutical industry Drug Discovery and Clinical Operations knowledge and Informatics. He has contributed in driving forward the vision of patient centricity and digital health at BI by promoting the Remote Clinical Trial model, and implementing several innovative digital health technologies in Clinical Trials to drive Patient Centricity. A great communicator with superb interpersonal skills, Hassan regularly interacts with key stakeholders to provide innovative solutions to critical problems. He is highly motivated in constantly seeking to improve processes and efficiency while driving innovation, and acts as a key contributor to multiple projects. Over the years, he has developed experience working in a global organization that requires collaboration with multidisciplinary international partners and is an invited guest speaker in several global Pharmaceutical and Clinical R&D conferences. Hassan is an active contributor to Transcelerate and the Clinical Trials Transformation Initiative (CTTI).

Session Details:

FIRESIDE CHAT Are We Committed to Not Going Back?

2023-05-23, 12:00 PM

View In Agenda
Next speaker
Back
Terry Katz
Sr. Director, Biostatistics and Data Management Planning and Functional Excellence, Daiichi Sankyo, Inc.

Terry Katz is Senior Director of Biostatistics and Data Management Planning and Functional Excellence at Daiichi Sankyo. Previously he was Head of Global Data Management and Statistics at Merck Animal Health, Head of Biometrics at ImClone Systems, Senior Manager of Analysis & Reporting for PRA International, and a Statistician at Schering-Plough. He holds Accreditation as a Professional Statistician and Certifications as a Quality Engineer and a Six Sigma Green Belt. He is Chair of DIA's GCP-QA Community; formerly he was a Core Committee member for NJ CDISC User Group and Chair of the Statistical Taskforce for the Animal Health Institute. Terry also completed a 3-month Fellowship in Kenya to improve capacity and capability for the local hospitals to run oncology clinical trials.

Session Details:

Leveraging study participants’ Real-World Data to enable researchers to confirm the representativeness of the baseline

2023-05-23, 2:00 PM

View In Agenda
Next speaker
Back
Keith Kennedy
Principal and Team Lead, Patient Cloud, Medidata

Keith Kennedy is a subject matter expert in eCOA/ePRO, eConsent, tele visits, wearables and other decentralized clinical trial tools. For over 15 years, Keith has consulted pharmaceutical, medical device and biotech companies on the best strategy to collect patient facing data in clinical trials in order to maximize patient compliance, increase data quality and decrease patient burden. A distinguished career in healthcare sales leadership, talent development and product education.

Session Details:

PANEL: Addressing the issues with Decentralised Clinical Trials and how we may work collaboratively to overcome them; addressing the pitfalls & challenges

2023-05-24, 12:00 PM

View In Agenda
Next speaker
Back
Ellen Weiss
Vice President, In-Home Solutions, Decentralized Clinical Trials, PCM Trials

Ellen Weiss is the Vice President, In-Home Solutions, Decentralized Clinical Trials at PCM Trials. Ellen brings decentralized clinical trial visits to patients with PCM Trials experienced Certified Mobile Research Nurses. She is mastering the logistics of dosing and testing clinical trial participants where they live, work, and study. With nearly a decade of home visits learnings, Ellen has a unique perspective on how decentralized clinical trials have changed over the years and what the future looks like.

Session Details:

The Last Millimeter is Everything: Essential Guide for Home Visits

2023-05-23, 11:30 AM

View In Agenda
Next speaker
Back
Travis Caudill
Vice President Feasibility, Site Identification & Clinical Informatics Feasibility & Site Identification Integration Workstream Lead, ICON

In my role, I am responsible for leading ICON’s country and site selection strategy ensuring that every project ICON undertakes benefits from a data-driven approach, optimized to reflect customer priorities, and with a probability of success calibrated to each customer’s risk preferences.

 

I started my journey working for a local health insurance company supporting actuarial (claims data) analysis, and then joined a local CRO to help them develop a data-driven site identification strategy to support their late phase studies.  Since then I’ve held a number of Feasibility, Site Identification, and Study Start-up focused roles across midsize and large CROs.

 

I’m an expert in trial modelling and leveraging artificial intelligence to inform country and site selection. I have really enjoyed helping to develop ICON’s OneSearch platform as well as leading initiatives to deliver next-generation scenario planning capabilities.  As we work to bring the best of both organizations together I’m excited about exploring new opportunities to excite and delight our customers through data-driven delivery.

 

Session Details:

Advancements in AI: turning big data into actionable intel for optimal site identification

2023-05-23, 11:30 AM

View In Agenda
Next speaker
Back
Sverre Bengtsson
Co-Founder, Viedoc

Sverre Bengtsson started in the clinical trials industry over 30 years ago. He started as a statistician/statistical programmer, later into data management and since over 20 years into business development. He has been working in both CRO’s as well as in clinical trials technology companies, including the global first ePRO company. Sverre is very interested in making clinical trials efficient, in both study design but also in the processes and technologies used. Sverre co-founded Viedoc Technologies 19 years ago and is responsible for some of the major accounts but also the vision around the company. He’s on the board of both some industry organisations and in clinical technology companies.

Next speaker
Back
Rohit Nambisan
CEO & Co-Founder, Lokavant

Trained as a neuroscientist, Rohit Nambisan is a product executive with experience leading product development organizations in pharma, medical devices, personalized medicine, health IT, healthcare data and analytics, and AI. Prior to co-founding and leading Lokavant, Rohit was most recently the Head of Digital Product at Roivant and the Head of Product at Prognos Health. Rohit holds an M.S in Management and Engineering from MIT, an M.A. in Neuroscience from Boston University, and a B.A in Cognitive Neuroscience from UC Berkeley.

Session Details:

Leveraging predictive analytics to improve patient retention, data quality, and enrollment outcomes in clinical trials

2023-05-24, 11:30 AM

View In Agenda
Next speaker
Back
Kevin Collier
VP, Medidata

Kevin is Vice President of Product with global responsibility for product strategy and delivery of
Medidata's RTSM solution. Kevin has spent his entire 30 year career in the Life Sciences arena
working in clinical research, medical devices, systems and software delivery, and project
management. Kevin has a well-rounded background that is technology focused and includes a deep
understanding of the Pharmaceutical industry and clinical trial life-cycle. Kevin first started in
IRT/RTSM at ICON Clinical Research in 2002 where he led the Project Management team responsible
for large clients and was instrumental in unique and innovative design initiatives.

Session Details:

Optimize Your Trial Execution with the Strategic Use of an Experienced Technology Solutions Team

2023-05-23, 10:00 AM

View In Agenda
Next speaker
Back
Alison Bedenkop
Senior Director, Patient Recruitment and Retention, Worldwide Clinical Trials

Alison Bedenkop is a Senior Director, Patient Recruitment and Retention at Worldwide Clinical Trials. Alison has been in clinical trial research for over 20 years, with the past 13 years focusing on global patient recruitment and retention.  Alison is passionate about diversity and inclusion and works towards building greater awareness of clinical trial opportunities in the local community.

Session Details:

Clinical Trial Liaisons’ Support of Psychedelic Clinical Trials

2023-05-23, 12:30 PM

View In Agenda
Next speaker
Back
Ted Kirby
Senior Director, Product Marketing, Saama

Ted Kirby is currently the Head of Product and Brand Marketing at Saama. Prior to Saama, Ted served as Senior Director, Product Marketing at Medidata, where he oversaw product marketing for Medidata's platform. He was previously Director of Account Management at Medable, where he oversaw commercial relationships with Medable’s key Pharmaceutical and CRO accounts. His previous experience also includes stints at AiCure, a VC-backed startup using visual artificial intelligence for medication adherence in clinical trials, Deloitte and IQVIA. Ted earned his undergraduate degree in business administration from the University of North Carolina at Chapel Hill and his MBA from Columbia Business School.

Session Details:

From Concept to Breakthrough: The Case for AI/ML in Clinical Development

2023-05-24, 9:30 AM

View In Agenda
Next speaker
Back
Neil Berger
Vice President, FSP Commercial and Operational Strategy, Parexel

As Vice President, FSP Commercial and Operational Strategy, Neil Berger is an operational and commercial strategist for clinical development outsourcing solutions at Parexel. Bringing 20 years of commercial and research operations experience, he is a recognized expert in holistic and cross-functional approaches to talent development – integrating acquisition, development and retention to meet long-term portfolio needs for biopharmaceutical sponsors.

 

Prior to joining Parexel in 2015 as a commercial account leader, Neil held a range of positions of increasing responsibility in project management and client services for Pharma Medica Research, a contract research organization based in Canada.

Neil earned a Master of Business Administration degree from Schulich School of Business, and holds a master’s and bachelor’s degree in science from McGill University.

Session Details:

A Clinical Outsourcing Model That’s As Agile As Your Development Program

2023-05-23, 2:30 PM

View In Agenda
Next speaker
Back
Dr Atul Gupta, MD
Vice President, Medical Services and Client Solutions, Navitas life Sciences

Atul is a physician with over 18 years’ experience in Clinical Research, Drug Development, and clinical practice, after getting education from top medical schools of India. Atul joined Navitas in February 2021, and prior to that he has worked with leading organizations like Ranbaxy, Panacea Biotec, Max Neeman International and Apcer Life Sciences. Atul has rich leadership experience in providing end to end scientific guidance in drug development (Phase 1-IV) across multiple therapeutic area portfolios, in diverse regulatory environments including FDA, EMA, MHRA, ANVISA and DCGI. Atul has been extensively involved in defending clinical strategy proposals with respect to scientific rationale, timelines and budget with senior executives. He has worked as Global Medical Lead (USA, Europe and Asia Pacific) in more than 50 studies across the continents for both drugs and devices. Atul has been involved extensively in developing complex innovative trial designs for complex protocols reducing the huge costs and time associated with standard clinical randomized controlled trials.

Apart from being a medical lead, atul has multifaceted experience in diverse clinical research domains including medical writing (Protocol, IB, CSR, eCTD etc), medico-regulatory (IND, NDA, BLA), drug safety and operations. Atul has been actively involved in multiple DSMBs and SRCs. He has been involved in negotiating clinical plans with FDA during pre-IND and type C meetings.  He has been the part of successful marketing authorization approval of breakthrough therapies including PD-1 inhibitors, V2 antagonist, multiple biosimilars, vaccines and several repurposed therapies (for MDD, narcolepsy, psoriasis)

Session Details:

Decentralization through Centralization: Thinking the Unthinkable in Clinical Trials

2023-05-23, 2:30 PM

View In Agenda
Next speaker
Back
Todd Rudo, MD
EVP & Chief Medical Officer, Clario

As Clario’s Chief Medical Officer, Dr. Todd Rudo provides medical and scientific leadership across the organization. Passionate about leveraging our scientific expertise to support our customers’ success, Dr. Rudo has focused efforts on optimizing our solutions across the therapeutic areas. His team supports Clario’s clients by providing expert consulting services on scientific and regulatory strategy, and ensures our product portfolio is scientifically robust, generating high quality data to support clinical trial endpoints. Dr. Rudo has a particular interest in applying innovative technologies to improve the scientific rigor of clinical trials, while maintaining focus on the customer experience, including minimizing patient and site burden. With nearly 20 years of clinical cardiology and pharmaceutical research experience, Dr. Rudo has focused his career predominantly on drug safety. He has worked within therapeutic areas including oncology, immuno-inflammatory diseases, urology, and cardiometabolic diseases, and has achieved board certifications in internal medicine, cardiology, cardiac electrophysiology, nuclear cardiology, and adult echocardiography.

Session Details:

Work smarter, not harder: Fulfilling your cardiac safety requirements without a Thorough QT (TQT) study

2023-05-24, 9:30 AM

View In Agenda
Next speaker
Back
Lauren Colfer
Former Vice President, Clinical Operations at Aceragen Pharmaceuticals

Lauren joins us with over 25 years of pharmaceutical development experience in both large and small pharmaceutical company settings.  Her career started as a clinical monitor with Covance which eventually led to oversight of clinical and medical affairs operations teams at Wyeth, Pfizer, Cephalon and Teva across multiple therapeutic areas.  Her biotech experience includes Head of Clinical Operations and Project Management at Recro Pharmaceuticals and, most recently, Head of Clinical Operations at Aceragen Pharmaceuticals (formerly Idera Pharmaceuticals).

Lauren holds a BS in Biology from the University of Scranton and an MBA in Biotechology and Health Industry Management from Pennsylvania State University.

Session Details:

PANEL DISCUSSION: What are the different outsourcing relationships and how do you manage them?

2023-05-24, 12:00 PM

View In Agenda
Next speaker
Back
Donna M. Mongiello, RN, BSN
Senior VP, Strategic Solutions, YPrime

Donna’s diverse career began in healthcare as a registered nurse and evolved to focus on technologies that support patients in clinical research.  Donna has published articles in trade journals and presented at pharmaceutical industry conferences on topics including patient centricity, improving enrollment success, eCOA, BYOD, and more.  With over 18 years in the clinical trials space, Donna currently serves as Senior Vice President, Strategic Solutions at YPrime, where she is responsible for developing and growing strategic partnerships.  Donna earned her Bachelor of Science degree in nursing from Thomas Jefferson University.

Session Details:

The Digital-First Future of Clinical Trials

2023-05-23, 12:30 PM

View In Agenda
Next speaker
Back
Joseph Im
Director, Digital Health Technologies Operations, Regeneron

Joe Im is currently the head of digital health technology operations at Regeneron.  He has 15 years of experience within the clinical trial space, where he’s been able to exercise his interest in cutting-edge technologies and his passion to improve the lives of patients. He has held positions on the supplier and sponsor sides within the COA project management function, as well as in imaging category management.  In his current role, he leads a team responsible for deploying and operating digital health technologies such as eCOA, sensor devices, digital apps, medical devices, and eClinical solutions in clinical trials. Joe has successfully led initiatives at Regeneron including the COA operations team development, adoption of eCOA BYOD as a standard modality, and development of a decentralized trial operating strategy.

Session Details:

The Digital-First Future of Clinical Trials

2023-05-23, 12:30 PM

View In Agenda
Next speaker
Back
David Cutler
Director, Project Management, WCG

David Cutler is the Director of Project Management at WCG for the EAC service line. David provides leadership to the WCG EAC organization and serves as a subject matter expert for management of endpoint adjudication committees. In his current role, David leads WCG’s EAC Project Management group with a focus on developing and managing expert committees in alignment with industry and regulatory best practices.

 

David has over 15 years industry experience and prior to joining WCG David worked in a variety of leadership roles in healthcare, academic, and nonprofit organizations building healthcare delivery programs and managing research teams. David spent the early part of his career developing and managing operations for NEURO-NET, a program aimed at improving long term outcomes for patients with catastrophic injuries. Prior to his focus on EACs, David’s work in clinical research was at a large public hospital building clinical research infrastructure enabling underserved patient populations to gain access to industry sponsored clinical trials and public/private grant funded research initiatives.

 

David holds a Bachelor of Arts in Psychology from the University of California Santa Cruz and a Master of Arts in Counseling, Health Psychology from Santa Clara University.

Session Details:

Outsourcing independent committees: benefits, operational considerations, and best practices

2023-05-24, 11:30 AM

View In Agenda
Next speaker
Back
Alex Ireland
Associate Director Business Development, Novotech

Alex Ireland is Associate Director Business Development at Novotech, the leading Asia Pacific centered global biotech CRO.  During her tenor, she has worked with 125+ biotech companies on 400+ studies in preparation for their upcoming Ph 1-3 clinical trials. Prior to joining Novotech, she worked for a small biotech company in a variety of business development and operational roles. Alex graduated from Boston University with a Master of Public Health.

 

Session Details:

Panel: Reversing the Conversation: What the clinical trial industry really wants from its service providers

2023-05-23, 12:00 PM

Session Details:

State of the Global Biotech Landscape: Where the opportunities lie

2023-05-23, 9:00 AM

View In Agenda
Next speaker
Back
Tom Gottschalk
Senior Director, Clinical Business Development TrialCard™, Mercalis

Tom Gottschalk has worked in the life sciences industry for over 25 years.  His first 10 years were spent as a Pharmaceutical Representative and Product Manager for Bertek Pharmaceuticals, Merck, and GSK.  He then joined RxSolutions as a commercial services account representative before transitioning into a focused clinical role after creating the RxStudy Card offering.  He joined Mercalis (formerly TrialCard) in 2019 via its acquisition of RxSolutions.  For over 12 years, Tom has been committed to changing the paradigm of the traditional clinical trial supply process through the RxStudy Card.

Session Details:

Innovative Processes to Better Address Today’s Trial Dynamics

2023-05-23, 4:30 PM

View In Agenda
Next speaker

Plan Your Visit

Venue

Valley Forge Casino Resort

1160 1st Ave, King of Prussia, PA 19406

Accommodation

Please be aware that should you be contacted by any 3rd party housing companies that they are not affiliated with us or the hotel.

Sponsors

Select a sponsor to learn more

FEATURED SPONSORS

SESSION SPONSORS

DRINKS RECEPTION SPONSOR

TECHNOLOGY SPOTLIGHT SPONSORS

EXHIBITORS

CO-SPONSORS

Media Centre

MEDIA PARTNERS

Enquiry

Contact Us

SPONSORSHIP ENQUIRIES

Nick McCudden

Head of OCT Events

SPEAKING OPPORTUNITIES

Maya Hudson

Senior Conference Producer

MARKETING ENQUIRIES

Moona Popal

Senior Marketing Manager

Sponsorship Enquiries

To enquire about sponsorship opportunities for the conference, please contact:

 

Nick McCudden

Head of OCT Events


Speaker Enquiries

To enquire about sponsorship opportunities for the conference, please contact:

 

Maya Hudson

Senior Conference Producer